Literature DB >> 8661963

Bone mass in Parkinson's disease: a study with three methods.

M Revilla1, G de la Sierra, F Aguado, L Varela, F J Jiménez-Jiménez, H Rico.   

Abstract

Recent reports suggest the presence of osteopenia in a high percentage of patients with Parkinson's disease (PD). These data contrast with previous reports of our group, perhaps due to the different methods used. We studied bone mass in 52 PD patients (28 males, 24 females) and in 80 age- and sex-matched controls (40 males, 40 females) who had no other disease that could affect bone mass. We measured the totally body bone mineral content (TBBMC) and the ultrasound bone velocity (UBV) of transmission in phalanx, and performed metacarpal radiogrammetry with computerized radiography (CCT). We also measured serum levels of total alkaline phosphatase and tartrate-resistant acid phosphatase, which were significantly increased in PD patients compared with controls (P < 0.0001). TBBMC was significantly lower in males (P < 0.05) and females (P < 0.05) with PD with respect to their controls. CCT did not differ significantly between the study groups. UBV was significantly lower in males with PD (P < 0.005), but similar in female PD and controls. These data suggest that the changes reported in bone mass in PD patients can depend on the sex and the study methods. We only found severe osteopenia in one male (3.6%) and five females (20.8%) with PD according to z-score. Only in women was no relationship found between TBBMC and severity of PD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661963     DOI: 10.1007/bf02509377

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  32 in total

1.  Comparison between metacarpal bone measurements by computarized radiogrammetry and total body DEXA in normal and osteoporotic women.

Authors:  H Rico; M Revilla; L F Villa; J F Martin-Santos; J L Cardenas; E Fraile
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

Review 2.  Clinical indications for bone mass measurements. A report from the Scientific Advisory Board of the National Osteoporosis Foundation.

Authors: 
Journal:  J Bone Miner Res       Date:  1989-11       Impact factor: 6.741

3.  Long-term influence of levodopa on bone mass and growth hormone in postmenopausal women with Parkinson's disease.

Authors:  H Rico; A Vazquez; J A Cabranes; L Cantizano; E R Hernandez; I Krisnik; E Varela de Seijas
Journal:  Clin Neuropharmacol       Date:  1987       Impact factor: 1.592

4.  Ultrasonics and selected physical properties of bone.

Authors:  W Abendschein; G W Hyatt
Journal:  Clin Orthop Relat Res       Date:  1970 Mar-Apr       Impact factor: 4.176

5.  [Bone changes in Parkinson's disease].

Authors:  F Ishizaki; T Harada; S Katayama; H Abe; S Nakamura
Journal:  No To Shinkei       Date:  1993-08

6.  Relationship between osteopenia and clinical characteristics of Parkinson's disease.

Authors:  F Ishizaki; T Harada; S Katayama; H Abe; S Nakamura
Journal:  Mov Disord       Date:  1993-10       Impact factor: 10.338

7.  Determinants of total-body and regional bone mineral content and density in postpubertal normal women.

Authors:  H Rico; M Revilla; L F Villa; M Alvarez del Buergo; D Ruiz-Contreras
Journal:  Metabolism       Date:  1994-02       Impact factor: 8.694

8.  Influence of weight and seasonal changes on radiogrammetry and bone densitometry.

Authors:  H Rico; M Revilla; J L Cardenas; L F Villa; E Fraile; F J Martín; I Arribas
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

Review 9.  Radiologic diagnosis of osteoporosis. Current methods and perspectives.

Authors:  S Grampp; M Jergas; C C Glüer; P Lang; P Brastow; H K Genant
Journal:  Radiol Clin North Am       Date:  1993-09       Impact factor: 2.303

10.  Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis.

Authors:  H Rico; M Revilla; F Arnanz; L F Villa; S Perera; I Arribas
Journal:  Obstet Gynecol       Date:  1993-02       Impact factor: 7.661

View more
  2 in total

1.  Prevalence and risk factors of osteoporosis in patients with Parkinson's disease.

Authors:  A Bezza; Z Ouzzif; H Naji; L Achemlal; A Mounach; M Nouijai; A Bourazza; R Mossadeq; A El Maghraoui
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

Review 2.  Bone health in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Kelli M Torsney; Alastair J Noyce; Karen M Doherty; Jonathan P Bestwick; Ruth Dobson; Andrew J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-03-11       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.